Analysts Offer Predictions for Harrow, Inc.'s Q2 2024 Earnings (NASDAQ:HROW)

Harrow, Inc. (NASDAQ:HROW – Free Report) – B. Riley dropped their Q2 2024 earnings per share (EPS) estimates for Harrow in a research report issued to clients and investors on Tuesday, May 14th. B. Riley analyst M. Mamtani now expects that the company will earn ($0.25) per share for the quarter, down from their previous […]

Related Keywords

Markl Baum , Craig Hallum , Jump Financial , Harrow Health Inc , Nasdaq , Rice Hall James Associates , Harrow Inc , Securities Exchange Commission , Kennedy Capital Management , Stifel Financial Corp , Pharmaceuticals Inc , Eton Pharmaceuticals Inc , Surface Ophthalmics Inc , Opaleye Management Inc , Free Report , Get Free Report , Capital Management , Financial Corp , Rice Hall James , Opaleye Management , Exchange Commission , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Daily ,